PROGNOSTIC VALUE OF INTRACELLULAR ADHESION MOLECULES IN HEMOLYTIC-UREMIC SYNDROME
- 作者: Moskalets O.V.1, Pankratenko T.E.1
-
隶属关系:
- Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
- 期: 卷 22, 编号 2-1 (2019)
- 页面: 426-428
- 栏目: ORIGINAL ARTICLES
- URL: https://medbiosci.ru/1028-7221/article/view/120239
- DOI: https://doi.org/10.31857/S102872210006919-5
- ID: 120239
如何引用文章
全文:
详细
The article presents the results of a study assessing the diagnostic and prognostic significance of determining the content of soluble intercellular adhesion molecules in children with typical and atypical hemolytic-uremic syndrome.
作者简介
O. Moskalets
Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
编辑信件的主要联系方式.
Email: 6816000@mail.ru
PhD, Leading Researcher, Research Laboratory,
Moscow
俄罗斯联邦T. Pankratenko
Moscow Regional Research and Clinical Institute named after M. F. Vladimirskij
PhD, Assistant Professor of Department of Transplantology, Nephrology and Artificial Organs, Faculty of Advanced Medical Studies,
Moscow
俄罗斯联邦参考
- Talarico V., Aloe M., Monzani A., Miniero R., Bona G. Hemolytic uremic syndrome in children. Minerva Pediatr.2016; 68(6), 441–445.
- Keir L. S., Marks S. D., Kim J. J. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies. Drug Des Devel Ther. 2012;6, 195–208.
- Loirat C., Frémeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011; 6, 60–66.
- Москалец О. В. Молекулы клеточной адгезии ICAM-1 и VCAM-1 при инфекционной патологии. Тихоокеанский медицинский журнал. 2018, 2, 21–25.
- Carter S., Hewitt I., Kausman J. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome. Nephrology(Cariton). 2017;22 (Suppl.1),7–10.
补充文件

